PuSH - Publikationsserver des Helmholtz Zentrums München

56 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Cebrià-Costa, J.P.* et al.: LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells. Oncogene 39, 79-121 (2020)
2.
Redondo Monte, E.* et al.: ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells. Oncogene 39, 3195–3205 (2020)
3.
Orth, M. ; Unger, K. ; Schoetz, U. ; Belka, C. & Lauber, K.: Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2. Oncogene 37, 52-62 (2018)
4.
Wang, X.* et al.: Insulin resistance in vascular endothelial cells promotes intestinal tumour formation. Oncogene 36, 4987-4996 (2017)
5.
Berscheminski, J.* et al.: Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation. Oncogene 35, 3178-3189 (2016)
6.
Bognar, M. et al.: Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas. Oncogene 35, 4269-4281 (2016)
7.
Nowicka, A.M.* et al.: A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization. Oncogene 35, 3125-3138 (2016)
8.
Wimmer, P.* et al.: PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53. Oncogene 35, 69–82 (2016)
9.
Baumgart, A.* et al.: Opposing role of Notch1 and Notch2 in a KrasG12D-driven murine non-small cell lung cancer model. Oncogene 34, 578–588 (2015)
10.
O'Flanagan, C.H.* ; Morais, V.A.* ; Wurst, W. ; de Strooper, B.* & O'Neill, C.*: The Parkinson's gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes. Oncogene 34, 1363-1374 (2015)
11.
Selmansberger, M.* et al.: CLIP2 as radiation biomarker in papillary thyroid carcinoma. Oncogene 34, 3917-3925 (2015)
12.
Nagel, D. ; Vincendeau, M. ; Eitelhuber, A.C. & Krappmann, D.: Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies. Oncogene 33, 5655-5665 (2014)
13.
Vereide, D.T.* et al.: Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 44, 1258-1264 (2014)
14.
Borsig, L.* ; Wolf, M.J.* ; Roblek, M.* ; Lorentzen, A.R. & Heikenwälder, M.: Inflammatory chemokines and metastasis - tracing the accessory. Oncogene 33, 3217-3224 (2013)
15.
Chaves-Perez, A. et al.: EpCAM regulates cell cycle progression via control of cyclin D1 expression. Oncogene 32, 641-650 (2013)
16.
Eißmann, M.* et al.: Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms. Oncogene 32, 2586–2591 (2013)
17.
Köchert, K.* et al.: High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas. Oncogene 30, 1831-1840 (2011)
18.
Tanori, M.* et al.: Opposite modifying effects of HR and NHEJ deficiency on cancer risk in Ptc1 heterozygous mouse cerebellum. Oncogene 30, 4740-4749 (2011)
19.
Scheller, H. et al.: c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma. Oncogene 29, 888-897 (2010)
20.
Wolf, M.J.* ; Seleznik, G.M.* ; Zeller, N.* & Heikenwälder, M.: The unexpected role of lymphotoxin β receptor signaling in carcinogenesis: From lymphoid tissue formation to liver and prostate cancer development. Oncogene 29, 5006-5018 (2010)